Mid-Term Hemodynamic and Clinical Results of the Stented Porcine Medtronic Mosaic Valve in Aortic Position

Thoracic and Cardiovascular Surgeon

Volumn 52, Issue 1, 2004, Pages 34-41

  Botzenhardt, F ^a   Gansera, Brigitte ^a   Kemkes, B M ^a  

^a KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

AOA; Aortic valve replacement; Heart valve bioprosthesis; Structural valve deterioration; Zero pressure

Indexed keywords

GLUTARALDEHYDE; OLEIC ACID;

AGED; AORTA PRESSURE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTERY DIAMETER; ARTICLE; BIOPROSTHESIS; BLEEDING; DEVICE; ENDOCARDITIS; EVALUATION; EXPLANT; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEMODYNAMIC MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PERFORMANCE; PRESSURE GRADIENT; PRIORITY JOURNAL; REOPERATION; SWINE; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEMODYNAMIC PROCESSES; HEMOLYSIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; REOPERATION; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 1542619563     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817800     Document Type: Article

References (20)

1. Grunkemeier GL, Bodnar E. Comparative assessment of bioprosthesis durability in the aortic position. J Heart Valve Dis 1995; 4: 49-55
2. Burdon TA, Miller DC, Oyer PE et al. Durability of porcine valves at fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg 1992; 103: 238-252
3. Fann JL, Miller DC, Moore KA et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg 1996; 62: 1301-1312
4. Vesley I. Analysis of the Medtronic Intact bioprosthesis valve. Effects of "zero-pressure" fixation. J Thorac Cardiovasc Surg 1991; 101: 90-99
5. Levy RJ. Glutaraldehyde and the calcification mechanism of bioprosthetic heart valves. J Heart Valve Dis 1994; 3: 101-104
6. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994; 90: 323-329
7. Duarte IG, MacDonald MJ, Cooper WA et al. In vivo hemodynamic, histologic and antimineralization characteristics of the Mosaic bioprosthesis. Ann Thorac Surg 2001; 71: 92-99
8. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller CM, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996; 62: 932-935
9. Banbury MK, Cosgrove DM, Thomas JD et al. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2002; 73: 1460-1465
10. Aupart MR, Sirinelli AL, Diemont FF, Meurisse YA, Dreyfus XB, Marchand MA. The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients. Ann Thorac Surg 1996; 61: 615-620
11. Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 2002; 124: 146-54
12. Jamieson WRE, Janusz MT, MacNab J, Henderson C. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement. Ann Thorac Surg 2001; 71: 282-284
13. Eichinger WB, Schütz A, Simmerl D et al. The Mosaic bioprosthesis in the aortic position: Hemodynamic performance after 2 years. Ann Thorac Surg 1998; 66: 126-129
14. Thomson DJ, Jamieson WRE, Dumesnil JG et al. Medtronic Mosaic porcine bioprosthesis: midterm investigational trial results. Ann Thorac Surg 2001; 71: S269-272
15. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000; 36: 1131-1141
16. Hanayama N, Christakis GT, Mallidi HR et al. Patient prosthesis mismatch is rare after aortic valve replacement: Valve size may be irrelevant. Ann Thorac Surg 2002; 73: 1822-1829
17. Jamieson WRE, Tyers GF, Miyagishima RT, Germann E, Janusz MT, Ling H. Carpentier-Edwards porcine bioprosthesis. Comparison of standard and supra-annular prosthesis at 7 years. Circulation 1991; 84 (Suppl 3): 145-152
18. Jamieson WRE, Lemieux MD, Sullivan JA, Munro AI, Metras J, Cartier PC. Medtronic Intact porcine bioprosthesis experience to twelve years. Ann Thorac Surg 2001; 71: 278-281
19. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc 2001; 121: 268-278
20. Mecozzi G, Milano AD, De Carlo M et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg 2002; 123: 550-556